The company plans to unveil the hyper-mega AI system with 600 billion machine learning parameters in the second half of 2021

LG_Twin_Towers

LG international headquarters in Seoul, South Korea. (Credit: Tocan Marius/Wikipedia)

LG Group has announced plans to invest over $100m to set up high-performance computing infrastructure to advance the development of artificial intelligence (AI).

The investment is planned to be made over the next three years.

LG AI Research, which is LG Group’s AI research and development unit, will build a hyper-mega AI system that resembles a human brain structure.

The AI system will be capable of processing huge amounts of data to perform independent learning, decision-making and actions.

To establish the system, LG plans to build a new computing system that will be capable of performing 95.7 quadrillion calculations per second.

The company plans to unveil the hyper-mega AI system with 600 billion machine learning parameters in the second half of this year, reported Yonhap News Agency.

It will have more than three times the parameters of GPT-3, which is the world’s largest autoregressive language model developed by OpenAI.

In addition to learning languages, LG’s advanced AI system will also be able to understand images and videos, while GPT-3 is capable of creating essays and have conversations similar to humans.

In partnership with 16 group affiliates, LG AI Research is also planning to build an AI model with trillion-scale parameters by the first half of 2022.

According to LG, the advanced AI system will have the potential for application in a range of industries from customer counselling to production development.

The system is also planned to be utilised by the company to explore new materials in the field of batteries and light-emitting compounds.

The conglomerate expects its AI model will be capable of analysing vast amounts of studies and patents in the field of chemistry to build a comprehensive database for new materials.

In addition, LG is planning to apply its AI solutions to develop vaccines for cancer treatment and environment-friendly plastics.